Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.

BACKGROUND Research on contingency management to treat excessive alcohol use is limited due to feasibility issues with monitoring adherence. This study examined the effectiveness of using transdermal alcohol monitoring as a continuous measure of alcohol use to implement financial contingencies to reduce heavy drinking. METHODS Twenty-six male and female drinkers (from 21 to 39 years old) were recruited from the community. Participants were randomly assigned to one of the two treatment sequences. Sequence 1 received 4 weeks of no financial contingency (i.e., $0) drinking followed by 4 weeks each of $25 and then $50 contingency management; Sequence 2 received 4 weeks of $25 contingency management followed by 4 weeks each of no contingency (i.e., $0) and then $50 contingency management. During the $25 and $50 contingency management conditions, participants were paid each week when the Secure Continuous Remote Alcohol Monitor (SCRAM-II™) identified no heavy drinking days. RESULTS Participants in both contingency management conditions had fewer drinking episodes and reduced frequencies of heavy drinking compared to the $0 condition. Participants randomized to Sequence 2 (receiving $25 contingency before the $0 condition) exhibited less frequent drinking and less heavy drinking in the $0 condition compared to participants from Sequence 1. CONCLUSIONS Transdermal alcohol monitoring can be used to implement contingency management programs to reduce excessive alcohol consumption.

[1]  G. Badger,et al.  Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. , 2000, Journal of consulting and clinical psychology.

[2]  Mikhail N. Koffarnus,et al.  A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adults. , 2011, Alcohol and alcoholism.

[3]  N. Petry,et al.  Vouchers versus prizes: contingency management treatment of substance abusers in community settings. , 2005, Journal of consulting and clinical psychology.

[4]  James G. Murphy,et al.  Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. , 2011, Drug and alcohol dependence.

[5]  P. Marques Levels and types of alcohol biomarkers in DUI and clinic samples for estimating workplace alcohol problems. , 2012, Drug testing and analysis.

[6]  R. Swift,et al.  Direct measurement of alcohol and its metabolites. , 2003, Addiction.

[7]  N. Petry,et al.  Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. , 2005, Journal of consulting and clinical psychology.

[8]  G. Matthijs,et al.  Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[9]  John Stufken,et al.  Optimal and Efficient Crossover Designs Under Different Assumptions About the Carryover Effects , 2003, Journal of biopharmaceutical statistics.

[10]  D. Kivlahan,et al.  Rewarding early abstinence in Veterans Health Administration addiction clinics. , 2013, Journal of substance abuse treatment.

[11]  D. Dougherty,et al.  Comparing the detection of transdermal and breath alcohol concentrations during periods of alcohol consumption ranging from moderate drinking to binge drinking. , 2012, Experimental and clinical psychopharmacology.

[12]  Michael Prendergast,et al.  Contingency management for treatment of substance use disorders: a meta-analysis. , 2006, Addiction.

[13]  K. Radonovich,et al.  Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. , 2000, Journal of consulting and clinical psychology.

[14]  Donelle N. Howell,et al.  Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker. , 2012, Journal of applied behavior analysis.

[15]  M. Hersen,et al.  Relative effectiveness of instructions, agreements, and reinforcement in behavioral contracts with alcoholics. , 1974, Journal of abnormal psychology.

[16]  G. Badger,et al.  Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. , 2007, Addiction.

[17]  N. Petry,et al.  Contingency management for treatment of substance abuse. , 2006, Annual review of clinical psychology.

[18]  R. Swift,et al.  Transdermal alcohol measurement for estimation of blood alcohol concentration. , 2000, Alcoholism, clinical and experimental research.

[19]  John O. Willis,et al.  Wechsler Abbreviated Scale of Intelligence , 2014 .

[20]  G. Badger,et al.  A meta-analysis of voucher-based reinforcement therapy for substance use disorders. , 2006, Addiction.

[21]  M. D. De Buyzere,et al.  Non-oxidative ethanol metabolites as a measure of alcohol intake. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[22]  Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. , 2000 .

[23]  Donelle N. Howell,et al.  Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol-dependent outpatients. , 2011, The American journal on addictions.

[24]  Anders Helander,et al.  Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. , 2012, Alcohol and alcoholism.

[25]  P. Miller A behavioral intervention program for chronic public drunkenness offenders. , 1975, Archives of general psychiatry.

[26]  Yuanyuan Liang,et al.  Accounting for sex-related differences in the estimation of breath alcohol concentrations using transdermal alcohol monitoring , 2014, Psychopharmacology.

[27]  N. Azrin,et al.  A community-reinforcement approach to alcoholism. , 1973, Behaviour research and therapy.

[28]  G. Badger,et al.  Outpatient behavioral treatment for cocaine dependence: One-year outcome. , 1995 .

[29]  N. Petry,et al.  Low-cost contingency management in community clinics: delivering incentives partially in group therapy. , 2007, Experimental and clinical psychopharmacology.

[30]  Scott Tippetts,et al.  Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives. , 2010, Addiction.

[31]  Alan K. Davis,et al.  Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians. , 2014, Journal of substance abuse treatment.

[32]  James D. Griffith,et al.  Contingency management in outpatient methadone treatment: a meta-analysis. , 2000, Drug and alcohol dependence.

[33]  M. Hersen,et al.  Contingent reinforcement of lowered blood-alcohol levels in an outpatient chronic alcoholic. , 1974, Behaviour research and therapy.

[34]  Donelle N. Howell,et al.  Duration effects in contingency management treatment of methamphetamine disorders. , 2013, Addictive behaviors.

[35]  N. Petry,et al.  A randomized study of cellphone technology to reinforce alcohol abstinence in the natural environment. , 2013, Addiction.

[36]  J. Hahn,et al.  Adding Fuel to the Fire: Alcohol’s Effect on the HIV Epidemic in Sub-Saharan Africa , 2011, Current HIV/AIDS reports.

[37]  N. Petry,et al.  Give them prizes, and they will come: contingency management for treatment of alcohol dependence. , 2000, Journal of consulting and clinical psychology.